UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade

Circulation (New York, N.Y.), 1998-10, Vol.98 (17), p.1783-1789

1998

Volltextzugriff (PDF)

In vivo inhibition of elevated myocardial β-adrenergic receptor kinase activity in hybrid transgenic mice restores normal β-adrenergic signaling and function

Circulation (New York, N.Y.), 1999-08, Vol.100 (6), p.648-653

1999

Volltextzugriff (PDF)

Catecholamines, cardiac beta-adrenergic receptors, and heart failure

Circulation (New York, N.Y.), 2000-04, Vol.101 (14), p.1634-1637

2000

Volltextzugriff (PDF)

In vivo ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

Circulation (New York, N.Y.), 2001-03, Vol.103 (9), p.1311-1316

2001

Volltextzugriff (PDF)

Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice

Circulation (New York, N.Y.), 2001-11, Vol.104 (20), p.2485-2491

2001

Volltextzugriff (PDF)

Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance

Circulation (New York, N.Y.), 2000-02, Vol.101 (4), p.408-414

2000

Volltextzugriff (PDF)

Intracoronary adenovirus-mediated delivery and overexpression of the β2-adrenergic receptor in the heart : Prospects for molecular ventricular assistance

Circulation (New York, N.Y.), 2000-02, Vol.101 (4), p.408-414

2000

Volltextzugriff (PDF)

Level of β-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure

Circulation (New York, N.Y.), 2005-02, Vol.111 (5), p.591-597

2005

Volltextzugriff (PDF)

Editorial: Selectivity in beta-adrenergic responses: clinical implications

Circulation (New York, N.Y.), 1974-05, Vol.49 (5), p.783-786

Lefkowitz, R J

1974

Volltextzugriff (PDF)

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

Circulation (New York, N.Y.), 1995-08, Vol.92 (3), p.277-277

Willerson, J T

1995

Volltextzugriff (PDF)

Selectivity in Beta-Adrenergic Responses: Clinical Implications

Circulation (New York, N.Y.), 1974-01, Vol.49 (5), p.783-786

LEFKOWITZ, ROBERT J.

1974

Volltextzugriff (PDF)

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)

Circulation (New York, N.Y.), 2016-06, Vol.133 (23), p.2254-2262

2016

Volltextzugriff (PDF)

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF

Circulation (New York, N.Y.), 2019-10, Vol.140 (17), p.1369-1379

2019

Volltextzugriff (PDF)

Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction

Circulation (New York, N.Y.), 2020-09, Vol.142 (13), p.1236-1245

2020

Volltextzugriff (PDF)

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

Circulation (New York, N.Y.), 2015-01, Vol.131 (1), p.54-61

2015

Volltextzugriff (PDF)

Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

Circulation (New York, N.Y.), 2024-07, Vol.150 (4), p.272-282

2024

Volltextzugriff (PDF)

Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial)

Circulation (New York, N.Y.), 2016-11, Vol.134 (22), p.1785-1787

2016

Volltextzugriff (PDF)

Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction

Circulation (New York, N.Y.), 2022-11, Vol.146 (18), p.1411-1414

2022

Volltextzugriff (PDF)

Abstract 17176: Burden and Prognostic Importance of Heart Failure Signs and Symptoms - Differences in Heart Failure With Preserved versus Reduced Ejection Fraction

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A17176-A17176

2020

Volltextzugriff (PDF)

Abstract 17063: Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A17063-A17063

2020

Volltextzugriff (PDF)

Abstract 12679: Impact of Mental Health Disorders on Ventricular Assist Device Supported Patients Emergency Resource Use and Outcomes

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A12679-A12679

2020

Volltextzugriff (PDF)

Abstract 17912: Health-related Quality of Life Outcomes in PARADIGM-HF

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A17912-A17912

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

SpracheRussisch

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(19)
Cardiovascular System & Cardiology
(19)
Life Sciences & Biomedicine
(19)
Peripheral Vascular Disease
(19)
Science & Technology
(19)
Heart Failure
(11)
Humans
(11)
Animals
(8)
Male
(8)
Biological And Medical Sciences
(6)
Cardiology. Vascular System
(6)
Female
(6)
Heart
(6)
Medical Sciences
(6)
Mice
(6)
Aged
(5)
Heart Failure - Physiopathology
(5)
Risk Factors
(5)
Angiotensin-Converting Enzyme Inhibitors - Therapeutic Use
(4)
Beta-Adrenergic Receptor Kinases
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade

In vivo inhibition of elevated myocardial β-adrenergic receptor kinase activity in hybrid transgenic mice restores normal β-adrenergic signaling and function

Catecholamines, cardiac beta-adrenergic receptors, and heart failure

In vivo ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice

Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance

Intracoronary adenovirus-mediated delivery and overexpression of the β2-adrenergic receptor in the heart : Prospects for molecular ventricular assistance

Level of β-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure

Editorial: Selectivity in beta-adrenergic responses: clinical implications

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

Selectivity in Beta-Adrenergic Responses: Clinical Implications

Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)

Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF

Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF

Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure

Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF

Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction

Abstract 13828: Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARADIGM-HF Proteomic Sub-Study

Abstract 17176: Burden and Prognostic Importance of Heart Failure Signs and Symptoms - Differences in Heart Failure With Preserved versus Reduced Ejection Fraction

Abstract 17063: Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure

Abstract 12679: Impact of Mental Health Disorders on Ventricular Assist Device Supported Patients Emergency Resource Use and Outcomes

Abstract 17912: Health-related Quality of Life Outcomes in PARADIGM-HF

Aktive Filter

Suchergebnisse filtern